Moreover, high FSCN1 scoring was associated with poorer tumor differentiation in serous, mucinous, and endometrioid adenocarcinoma, indicating a role of FSCN1 in analyzing tumor aggressiveness, and was suggested as an independent prognostic risk factor in mucinous carcinoma [138]. This evidence concerns the gene FSCN1 and mucinous adenocarcinoma.